Université Saint-Joseph (USJ) / جامعة القديس يوسف / Սուրբ Ժոզեֆի համալսարան

Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study (2023) Ali SS, Naveen R, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, et al. Journal article Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey (2023) Naveen R, Thakare D, Kuwana M, Pauling J, Day J, Joshi M, Parodis I, et al. Journal article Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys (2023) Sen P, Naveen R, Houshmand N, Kia SM, Joshi M, Saha S, Jagtap K, et al. Journal article An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists (2023) Donskov AO, Mackie SL, Hauge EM, Toro-Gutierrez CE, Hansen IT, Hemmig AK, Van Der Maas A, et al. Journal article Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study (2023) Sandhu NK, Ravichandraan N, Nune A, Day J, Sen P, Nikiphorou E, Tan AL, et al. Journal article Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study. (2023) Naveen R, Nikiphorou E, Joshi M, Sen P, Lindblom J, Agarwal V, Lilleker JB, et al. Journal article Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study (2023) Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, et al. Journal article High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey (2023) Grignaschi S, Kim M, Zanframundo G, Ravichandran N, Lilleker JB, Sen P, Joshi M, et al. Journal article Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study (2023) Shinjo SK, Kim M, Hoff LS, Missé RG, Sen P, Naveen R, Day J, et al. Journal article Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study (2022) Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, et al. Journal article, Letter